Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
SAN DIEGO & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx® Corp. today announced positive one-year results from the U.S. LIBERATE pivotal trial of the Zephyr® Endobronchial Valve, a ...
Daily, people all around West Michigan and the world feel like they are suffocating. It's not because of the stress daily life can bring, but because of a condition known as COPD with Emphysema. The ...
Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and Texas REDWOOD CITY, Calif., Nov. 02, 2020 ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System for treating severe emphysema ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...
The approval was based on results from a multicenter study (LIBERATE) of 190 patients with severe emphysema. The Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx ...
Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...
The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...
The FDA today approved the Zephyr endobronchial valve for treating breathing difficulty associated with severe emphysema, according to a press release. “Treatment options are limited for people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback